About this trial
The goal of this observational study is to determine if a COPD exacerbation can be detected early in its onset. The main questions it aims to answer are:
* Can an exacerbation be detected before the person recognizes they are unwell? * What are the biological signals which provide the best indication of decompensation? * How does this indication of decompensation compare to a daily CAT?
Participants will be asked to place a device, DistaSense, on top of their mattress and then sleep as normal. In addition, they will be asked to complete a daily CAT.
Eligibility criteria
Qualifiers
Confirmed diagnosis of COPD
1 or more exacerbation in the last year
Aged over 18 years
Willing to use monitoring devices and complete study questionnaires
Disqualifiers
Pregnancy
BMI greater than 45 kg/m2
Nil other, provided inclusion criteria are met.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
Sponsors and collaborators
Life Detection Technologies
Lead sponsor
Royal Free Hospital NHS Foundation Trust
Collaborator